profit from every $100 of sales.
$0$100
P3 Health Partners
$2.70-1.82% today
-61.4% in 1 year
1-year low $1.521-year high $16.47
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What P3 Health Partners sold, what it kept, and what it did with the cash.
Sales went from $1.05 billion in 2022 to $1.46 billion in 2025, with -$148 million of profit last year.
SalesProfit
P3 Health Partners vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| P3 Health Partners | No profit yet | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
AI analysis
An AI analyst reads P3 Health Partners's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1,049 | 1,266 | 1,500 | 1,459 | |
| – | – | – | – | |
| -246 | -168 | -313 | -270 | |
| -1,461 | -81 | -198 | -182 | |
| -270 | -58 | -136 | -148 | |
| -325.00 | -31.50 | -54.00 | -45.26 | |
| – | – | – | – | |
| -23.4% | -13.3% | -20.8% | -18.5% | |
| -25.7% | -4.6% | -9.1% | -10.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 877 | 861 | 783 | 657 |
| Cash | 18 | 36 | 39 | 25 |
| Total debt | 106 | 122 | 195 | 285 |
| Total liabilities | 354 | 427 | 634 | 797 |
| 6 | 142 | 76 | -155 | |
| 1 | 6 | 3 | 3 | |
| -1,094.1% | -50.2% | -82.6% | -162.1% | |
| -4,614.4% | -40.6% | -178.9% | 95.3% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -126 | -76 | -110 | -91 | |
| 2 | 2 | – | – | |
| -128 | -78 | -110 | -91 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 19 | 6 | 6 | 6 |
Valuation
- –
- –
- –
- -0.1×
- 0.4×
- –
- –
- -16.3%
- -26.4%
- 0.0%
Profitability
- 18.0%
- -18.5%
- -10.1%
- -12.8%
- -172.8%
- -94.2%
- 893.8%
- -22.5%
- -242.7%
- –
Growth
- +11.6%
- –
- +17.2%
- –
- +40.8%
Financial health
- –
- -0.36
- 8.6%
- -4.9×
- 0.24
- 0.24
- 2.22
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 898
Top 47%of 911
Bottom 4%of 991
What analysts expect
- Average price target
- $4.00
- Range
- $4.00 – $4.00
- 1 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 14, 2026 | 0.32 | -4.85 | +106.6% |
| Mar 26, 2026 | -23.02 | -8.06 | −185.5% |
| Nov 14, 2025 | -9.67 | -5.29 | −82.7% |
| Aug 14, 2025 | -6.23 | -3.29 | −89.4% |
| May 15, 2025 | -6.28 | -5.00 | −25.6% |
| Mar 27, 2025 | -16.00 | -8.50 | −88.2% |
| Nov 12, 2024 | -15.50 | -1.50 | −933.3% |
| Aug 7, 2024 | -7.50 | -4.00 | −87.5% |
News
GLP-1s can save health system money if priced below $350 a month: analysisSeeking Alpha · Nov 14, 2026How to figure out a key question this open-enrollment season: Are you overpaying for health insurance?MarketWatch · Nov 13, 2026Obamacare Subsidies Lapsed. Here's Why Health Insurer Stocks Are Watching the New Congress.Yahoo Finance · Nov 8, 2026Notable healthcare headlines for the week: Moderna, Pfizer, and CVS Health in focusSeeking Alpha · Nov 8, 2026The Healthcare ETF Showdown: Broad Global Health or Targeted Pharma Power?Yahoo Finance · Nov 7, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
9No pass
Benjamin Graham
0No pass
Philip Fisher
23No pass
Peter Lynch
28No pass
Joel Greenblatt
0No pass
Charlie Munger
10No pass
Terry Smith
12No pass
Questions about P3 Health Partners
Is P3 Health Partners a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the P3 Health Partners AI analysis
What does P3 Health Partners do?
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada. It is in Medical - Care Facilities, based in Henderson, NV, United States, with 320 employees.
Does P3 Health Partners pay a dividend?
No. P3 Health Partners does not pay a dividend at the moment.
Is P3 Health Partners stock halal?
No. P3 Health Partners does not pass our halal screen: its debt is 51% of its market value, at or above the 33% limit. How we check
How has P3 Health Partners stock done over the past year?
Down 61.4% over the past twelve months, to $2.70. It traded between $1.52 and $16.47 and is 83.6% below its high.
Who are P3 Health Partners's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with P3 Health Partners's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.